Overview

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.
Phase:
Phase 3
Details
Lead Sponsor:
Vanda Pharmaceuticals
Treatments:
Neurokinin-1 Receptor Antagonists